NZ's Rua Bioscience rises on regulatory nod to produce cannabinoid oil

Rua Bioscience

27/09/2021 23:48

** Medicinal cannabis company Rua Bioscience's  RUA.NZ 
shares rise 3.9% to NZ$0.41, biggest intraday pct gain since
Aug. 31
    ** Company says it received GMP licence from Medsafe, NZ's
medical regulatory body, to manufacture its first medicinal
cannabis product, a cannabinoid oil  urn:newsml:reuters.com:*:nNZW75wrWl
    ** The license is a pre-requisite for both domestic and
export sale - Rua Bioscience CEO Rob Mitchell
    ** Stock hits highest since Sept. 17
    ** About 138,000 shares change hands vs 30-day avg volume of
68,000
    ** Stock second-biggest pct gainer on S&P NZX All Capital
index  .NZCI 
    ** Stock on track to post second consecutive session of gain
    ** Company's shares down 35% this year, as of last close

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))